• Fund Type: Open-End Fund
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: Global

Allianz Biotechnologie

+ Add to Watchlist

DJFF:TH

159.3440 EUR 0.00000.00%

As of 03:05:38 ET on 01/22/2015.

Snapshot for Allianz Biotechnologie (DJFF)

Open: - High - Low: - Primary Exchange: Tradegate
Volume: 40 52-Week Range: 97.7700 - 159.3440 Beta vs NBI: 0.8756

ETF Chart for DJFF

No chart data available.
  • DJFF:TH 159.3440
  • 1D
  • 1M
  • 1Y
159.3440
Interactive DJFF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DJFF

Allianz Biotechnologie is an open-end investment fund incorporated in Germany. The Fund's objective is growth. The Fund invests primarily in stocks, warrants and profit sharing certificates. The Fund may also invest in bonds withwarrants and convertible debentures issued by pharmaceutical and biotechnology corporations worldwide.

Inception Date: 1998-01-09 Telephone: 49-69-24431-140 Tel
Managers: -
Web Site: www.allianzglobalinvestors.de

Fundamentals for DJFF

NAV -
Assets (M) (on 2015-01-23) 361.8030
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for DJFF

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for DJFF

1-Month +13.83% 1-Year +37.29%
3-Month +26.60% 3-Year -
Year To Date - 5-Year -
Expense Ratio 2.05

Top Fund Holdings for DJFF

Filing Date: 07/31/2014
Name Position Value % of Total
Biogen Idec Inc 88,920 22,871,971 8.672%
Alexion Pharmaceuticals Inc 157,710 19,272,788 7.308%
Celgene Corp 252,310 16,641,082 6.310%
Vertex Pharmaceuticals Inc 223,500 15,353,319 5.821%
Amgen Inc 129,800 12,599,147 4.777%
Puma Biotechnology Inc 72,385 12,132,081 4.600%
Medivation Inc 206,770 11,771,101 4.463%
Shire PLC 60,000 11,254,592 4.267%
Actelion Ltd 125,000 11,236,841 4.261%
Gilead Sciences Inc 154,450 10,815,190 4.101%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil